Insulin Detemir Recombinant Patent Expiration
Insulin Detemir Recombinant is Used for managing diabetes mellitus by providing long-acting basal insulin. It was first introduced by Novo Nordisk Inc
Insulin Detemir Recombinant Patents
Given below is the list of patents protecting Insulin Detemir Recombinant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Levemir Flexpen | US9265893 | Injection button | Sep 23, 2032 | Novo Nordisk Inc |
| Levemir Flextouch | US9132239 | Dial-down mechanism for wind-up pen | Feb 01, 2032 | Novo Nordisk Inc |
| Levemir Flextouch | US9457154 | Injection device with an end of dose feedback mechanism | Sep 27, 2027 | Novo Nordisk Inc |
| Levemir Flextouch | US9687611 | Injection device with torsion spring and rotatable display | Feb 27, 2027 | Novo Nordisk Inc |
| Levemir Flextouch | US7686786 | Dial-down mechanism for wind-up pen | Aug 03, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | USRE46363 | Dial-down mechanism for wind-up pen | Aug 03, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism | Jul 17, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | Jul 17, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | Jul 17, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US10357616 | Injection device with an end of dose feedback mechanism | Jan 20, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US10376652 | Automatic injection device with a top release mechanism | Jan 20, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US9108002 | Automatic injection device with a top release mechanism | Jan 20, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US9616180 | Automatic injection device with a top release mechanism | Jan 20, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US9861757 | Injection device with an end of dose feedback mechanism | Jan 20, 2026 | Novo Nordisk Inc |
| Levemir Flextouch | US8684969 | Injection device with torsion spring and rotatable display | Oct 20, 2025 | Novo Nordisk Inc |
| Levemir Flextouch | US7762994 | Needle mounting system and a method for mounting a needle assembly |
May 23, 2024
(Expired) | Novo Nordisk Inc |
| Levemir Flextouch | US8579869 | Needle mounting system and a method for mounting a needle assembly |
Jun 30, 2023
(Expired) | Novo Nordisk Inc |
| Levemir Flextouch | US6899699 | Automatic injection device with reset feature |
Jan 02, 2022
(Expired) | Novo Nordisk Inc |
| Levemir Flextouch | US8672898 | Automatic injection device with reset feature |
Jan 02, 2022
(Expired) | Novo Nordisk Inc |
| Levemir Flextouch | US9486588 | Automatic injection device with reset feature |
Jan 02, 2022
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | USRE41956 | Dose setting limiter |
Jan 21, 2021
(Expired) | Novo Nordisk Inc |
| Levemir | US5750497 | Acylated insulin |
Jun 16, 2019
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | US5750497 | Acylated insulin |
Jun 16, 2019
(Expired) | Novo Nordisk Inc |
| Levemir Flextouch | US5750497 | Acylated insulin |
Jun 16, 2019
(Expired) | Novo Nordisk Inc |
| Levemir Innolet | US5750497 | Acylated insulin |
Jun 16, 2019
(Expired) | Novo Nordisk Inc |
| Levemir Penfill | US5750497 | Acylated insulin |
Jun 16, 2019
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | US6004297 | Injection syringe |
Jan 28, 2019
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | USRE43834 | Injection syringe |
Jan 28, 2019
(Expired) | Novo Nordisk Inc |
| Levemir | US5866538 | Insulin preparations containing NaCl |
Jun 20, 2017
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | US5866538 | Insulin preparations containing NaCl |
Jun 20, 2017
(Expired) | Novo Nordisk Inc |
| Levemir Flextouch | US5866538 | Insulin preparations containing NaCl |
Jun 20, 2017
(Expired) | Novo Nordisk Inc |
| Levemir Innolet | US5866538 | Insulin preparations containing NaCl |
Jun 20, 2017
(Expired) | Novo Nordisk Inc |
| Levemir Penfill | US5866538 | Insulin preparations containing NaCl |
Jun 20, 2017
(Expired) | Novo Nordisk Inc |
| Levemir | US6011007 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir | US6869930 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | US6011007 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir Flexpen | US6869930 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir Innolet | US6011007 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir Innolet | US6869930 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir Penfill | US6011007 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
| Levemir Penfill | US6869930 | Acylated insulin |
Feb 02, 2014
(Expired) | Novo Nordisk Inc |
Insulin Detemir Recombinant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List